Stay informed with the latest updates for the inheritable blood disorders community. Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program Updates Jan 10, 2023 Industry Takeda Announces Trial Results on Investigational Therapy for… Jan 10, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy… Jan 4, 2023 Industry Spark Announces SPK-8011 Updates at ASH Dec 15, 2022 Medical First Hemophilia B Gene Therapy Approved by FDA Nov 23, 2022 Medical New Document to Help Residential Substance… Nov 14, 2022 Industry BioMarin Shares Community Update for Valoctocogene Roxaparvovec Oct 3, 2022 Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Medical Update for the Hemophilia Community Sep 12, 2022 Medical Virtual Grand Round Series to Focus on Hemophilia Gene Therapy Sep 12, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001 Sep 6, 2022 Industry Rare Factor X Deficiency Survey Shows Disparity in Care Sep 1, 2022 Industry BioMarin Receives Conditional Approval in Europe for Gene Therapy Aug 25, 2022 Medical PPTA Posts Statement on Monkeypox and Plasma Protein Therapies Aug 22, 2022 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page